share_log

40 Stocks Moving In Wednesday's Mid-Day Session

40 Stocks Moving In Wednesday's Mid-Day Session

週三午盤，40只股票走勢震盪
Benzinga Real-time News ·  2021/11/24 12:02

Gainers

贏家

  • Biofrontera Inc. (NASDAQ:BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
  • Longeveron Inc. (NASDAQ:LGVN) gained 48.1% to $25.50 after tumbling 39% on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
  • Ocuphire Pharma, Inc. (NASDAQ:OCUP) jumped 38% to $4.80 after the company announced that the first subjects have been enrolled in the MIRA-3 Phase 3 pivotal trial evaluating Nyxol Eye Drops in the reversal of pharmacologically-induced mydriasis.
  • Better Therapeutics, Inc. (NASDAQ:BTTX) shares gained 29% to $8.32 after Chardan Capital initiated coverage on the stock with a Buy rating and a $17 price target.
  • Bridgeline Digital, Inc. (NASDAQ:BLIN) jumped 23.5% to $3.43.
  • Grom Social Enterprises, Inc. (NASDAQ:GROM) gained 23.5% to $2.78. Grom Social Enterprises disclosed that its newest division, Curiosity Ink Media, unwrapped Santa.com.
  • Benessere Capital Acquisition Corp. (NASDAQ:BENE) jumped 21.3% to $12.34. eCombustible Energy will merge with Benessere Capital Acquisition Corp. in a $805 million deal.
  • Spark Networks SE (NYSE:LOV) gained 15% to $3.0699. Spark Networks 10% owner Osmium Diamond Lp acquired a total of 1654197 shares at an average price of $2.51.
  • Local Bounti Corporation (NYSE:LOCL) jumped 14.8% to $9.20.
  • BIOLASE, Inc. (NASDAQ:BIOL) rose 14.4% to $0.4810 after Nasdaq granted the company 180-day extension to meet minimum bid price requirement. The company also entered into favorable credit deal.
  • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) gained 12.6% to $3.83. Reviva Pharmaceuticals recently posted a Q3 loss of $0.12 per share.
  • Engine Gaming and Media, Inc. (NASDAQ:GAME) rose 12.5% to $3.5780 after the company reported Q4 2021 and FY21 revenue was higher year over year.
  • Pure Storage, Inc. (NASDAQ:PSTG) rose 10.8% to $30.23 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 and FY22 sales guidance above estimates.
  • Golden Ocean Group Limited (NASDAQ:GOGL) rose 9% to $8.71 after reporting Q3 results.
  • HP Inc. (NYSE:HPQ) rose 9% to $35.10 after the company reported better-than-expected results for its fourth quarter and issued strong earnings forecast for the current quarter.
  • Meiwu Technology Company Limited (NASDAQ:WNW) shares rose 6.1% to $3.31.
  • Biofrontera Inc.納斯達克(Standard Chartered Bank：BFRI)股價上漲109.5%，至5.51美元，此前羅斯資本對該股的評級為買入，目標價為20美元。
  • 隆格韋隆公司(Longeveron Inc.)納斯達克(Sequoia Capital：LGVN)在週二暴跌39%後，上漲48.1%，至25.5美元。該公司上週宣佈，FDA授予Lomecel-B治療左心發育不良綜合徵的罕見兒科疾病稱號。
  • 奧克菲爾製藥公司(Ocuphire Pharma，Inc.)納斯達克(Starbucks：OCUP)股價上漲38%，至4.8美元，此前該公司宣佈，首批受試者已參加MIRA-3期3期關鍵試驗，評估尼索爾滴眼液逆轉藥物性散瞳的作用。
  • Better Treateutics，Inc.納斯達克(Standard Chardan Capital：BTTX)股價上漲29%，至8.32美元，此前查爾丹資本對該股的評級為買入，目標價為17美元。
  • Bridgeline Digital，Inc.納斯達克(BLIN：BLIN)跳漲23.5%，報3.43美元。
  • 格羅姆社會企業公司納斯達克(Starbucks：Grom)上漲23.5%，至2.78美元。格羅姆社會企業(Grom Social Enterprise)透露，其最新部門好奇號墨水傳媒(Curiity Ink Media)解開了Santa.com。
  • 貝內斯爾資本收購公司納斯達克(Sequoia Capital：BENE)跳漲21.3%，報12.34美元。ECombusable Energy將與Benessere Capital Acquisition Corp.合併，交易金額為8.05億美元。
  • 星火網絡SE(紐約證券交易所股票代碼：LOV)上漲15%，至3.0699美元。星火網絡10%的持有者歐司曼鑽石有限責任公司以2.51%的平均價格收購了總計1654197股。
  • 當地邦蒂公司(紐約證券交易所代碼：Locl)股價上漲14.8%，至9.20美元。
  • Biolase，Inc.納斯達克(Sequoia Capital：BIOL)股價上漲14.4%，至0.4810美元，此前納斯達克批准該公司延期180天，以滿足最低投標價格要求。該公司還達成了優惠的信貸交易。
  • Reviva製藥控股公司(Reviva PharmPharmticals Holdings，Inc.)納斯達克(Sequoia Capital：RVPH)上漲12.6%，至3.83美元。Reviva PharmPharmticals最近公佈第三季度每股虧損0.12美元。
  • Engine Gaming and Media，Inc.納斯達克(GAME：GAME)股價上漲12.5%，至3.5780美元，此前該公司公佈2021年第四季度和21財年營收同比增長。
  • Pure Storage，Inc.納斯達克(Sequoia Capital：PSTG)股價上漲10.8%，至30.23美元，此前該公司公佈了好於預期的第三季度每股收益和銷售業績，併發布了高於預期的第四季度和22財年銷售指引。
  • 金海集團有限公司納斯達克(GOGL：GOGL)公佈第三季度財報後，股價上漲9%，至8.71美元。
  • 惠普公司惠普(NYSE：HPQ)上漲9%，報35.10美元，此前該公司公佈第四季業績優於預期，併發布強勁的當前季度獲利預估。
  • 美物科技有限公司納斯達克(Sequoia Capital：WNW)股價上漲6.1%，至3.31美元。


Check out these big penny stock gainers and losers


看看這些微不足道的股票贏家和輸家

Losers

失敗者

  • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 34.3% to $4.79 after jumping over 80% on Tuesday.
  • Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares dipped 30.9% to $1.7699 after jumping around 105% on Tuesday.
  • Pasithea Therapeutics Corp. (NASDAQ:KTTA) declined 30.2% to $3.9100. Pasithea Therapeutics priced its 8.68 million share private placement at $3.50 per share.
  • Nordstrom, Inc. (NYSE:JWN) shares fell 28.5% to $22.81 after the company reported worse-than-expected Q3 sales results. Jefferies downgraded Nordstrom from Buy to Hold and lowered the price target from $48 to $30.
  • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 26.1% to $1.7294 after jumping over 75% on Tuesday.
  • Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 25.4% to $12.70. Aptevo Therapeutics shares climbed 163% on Tuesday after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 in the treatment of AML. Preliminary data observed to date includes one complete remission.
  • Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares fell 23.6% to $7.64 after surging over 40% on Tuesday.
  • The Gap, Inc. (NYSE:GPS) fell 21.5% to $18.44 after the company reported worse-than-expected Q3 EPS and sales results and cut FY21 adjusted EPS guidance below estimates.
  • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares fell 21.5% to $4.5001. Clarus Therapeutics shares jumped 43% on Tuesday after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
  • iSpecimen Inc. (NASDAQ:ISPC) fell 21% to $10.42. iSpecimen shares jumped over 48% on Tuesday on continued upward momentum after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
  • Outlook Therapeutics, Inc. (NASDAQ:OTLK) fell 20.5% to $1.24 after the company reported a $10 million bought deal offering of common stock.
  • Gracell Biotechnologies Inc. (NASDAQ:GRCL) fell 19.5% to $6.27. Gracell Biotechnologies shares gained 22% on Tuesday after the company reported members of its senior management team intend to use personal funds to buy up to $2 million in company ADSs in the open market over the next 3 months.
  • Anaplan, Inc. (NYSE:PLAN) shares fell 18.8% to $42.28 after the company reported Q3 earnings results. Piper Sandler downgraded Anaplan from Overweight to Neutral and lowered the price target from $77 to $48.
  • Kura Oncology, Inc. (NASDAQ:KURA) declined 16% to $13.95 after the company announced the FDA placed the KOMET-001 Phase 1b study of KO-539 in patients with relapsed or refractory acute myeloid leukemia (AML) on a partial clinical hold.
  • Noah Holdings Limited (NYSE:NOAH) dropped 15.7% to $37.12 following Q3 results. JP Morgan downgraded Noah Holdings from Overweight to Neutral and announced a $50 price target.
  • MediciNova, Inc. (NASDAQ:MNOV) shares fell 14.7% to $3.7689 after surging 44% on Tuesday.
  • Autodesk, Inc. (NASDAQ:ADSK) shares fell 14.6% to $259.28. Autodesk reported upbeat results for its third quarter, but issued disappointing guidance. Autodesk said it sees Q4 revenue of $1.185 billion to $1.2 billion and non-GAAP earnings of $1.41 to $1.47 per share.
  • Viomi Technology Co., Ltd (NASDAQ:VIOT) slipped 14.2% to $3.50 following Q3 results.
  • NerdWallet, Inc. (NASDAQ:NRDS) dropped 13% to $22.10. The company recently priced its IPO at $4 per share.
  • Nuvation Bio Inc. (NYSE:NUVB) fell 12.3% to $8.10.
  • TDCX Inc. (NYSE:TDCX) dropped 10.8% to $20.19 following Q3 results.
  • Dillard's, Inc. (NYSE:DDS) fell 9.2% to $372.59.
  • Abercrombie & Fitch Co. (NYSE:ANF) fell 6.4% to $38.49. Abercrombie & Fitch recently reported third-quarter FY21 sales growth of 10% year-on-year, to $905.16 million, beating the analyst consensus of $896.86 million.
  • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) fell 6.4% to $6.15 after the company received anticipated letter from Nasdaq regarding form 10-Q filing.
  • 瓦隆製藥公司納斯達克(Sequoia Capital：VLON)週二跳漲逾80%後下跌34.3%，至4.79美元。
  • 誇里根治療公司(Qualigen Treateutics，Inc.)納斯達克(Starbucks：QLGN)股價週二跳漲約105%，至1.7699美元，跌幅為30.9%。
  • 帕西婭治療公司(Pasithea Treateutics Corp.)納斯達克(KTTA：KTTA)下跌30.2%，至3.9100美元。帕西婭治療公司(Pasithea Treeutics)將其868萬股私募定價為每股3.50美元。
  • 諾德斯特龍公司(紐約證券交易所代碼：JWN)股價下跌28.5%，至22.81美元，此前該公司公佈的第三季度銷售業績遜於預期。Jefferies將諾德斯特龍的評級從買入下調至持有，並將目標價從48美元下調至30美元。
  • Petros製藥公司納斯達克(Sequoia Capital：PTPI)週二暴跌26.1%，報1.7294美元，盤中一度躍升逾75%.
  • Aptevo治療公司納斯達克(Alipay：APVO)跌25.4%，報12.7美元。Aptevo治療公司股價週二上漲163%，此前該公司宣佈了評估APVO436治療AML的1b期擴大試驗的臨牀更新。到目前為止觀察到的初步數據包括一次完全緩解。
  • Esperion治療公司納斯達克(Sequoia Capital：ESPR)股價週二飆升逾40%後，下跌23.6%，至7.64美元。
  • The Gap，Inc.(紐約證券交易所股票代碼：GPS)股價下跌21.5%，至18.44美元，此前該公司公佈的第三季度每股收益和銷售業績遜於預期，並將21財年調整後每股收益指引下調至低於預期。
  • 克拉魯斯治療控股公司(Clarus Treateutics Holdings，Inc.)納斯達克(Starbucks：CRXT)股價下跌21.5%，至4.5001美元。克拉魯斯治療公司(Clarus Treeutics)週二股價上漲43%，此前該公司獲得了一項名為“口服睾酮酯配方和治療睾酮缺乏症的方法”的美國專利。
  • ISpecimen Inc.納斯達克(Sequoia Capital：ISPC)下跌21%，至10.42美元。在宣佈簽約支持新冠肺炎新的高級研究後，iSpecimen的股價週二上漲超過48%，該公司宣佈已經簽約支持微博的新的高級研究，尋求對微博的傳播性、變種、結果和在多個人羣中測試有效性的見解。
  • Outlook治療公司納斯達克(Starbucks：OTLK)股價下跌20.5%，至1.24美元，此前該公司公佈以1,000萬美元買入普通股。
  • 亙喜生物(Sequoia Capital Inc.)納斯達克(GRCL：GRCL)跌19.5%，報6.27美元。亙喜生物週二股價上漲22%，此前該公司報道稱，其高級管理團隊成員打算在未來3個月內利用個人資金在公開市場購買高達200萬美元的公司美國存託憑證。
  • Anaplan，Inc.(紐約證券交易所股票代碼：PLAN)股價下跌18.8%，至42.28美元，此前該公司公佈了第三季度收益業績。Piper Sandler將Anaplan評級從加碼下調至中性，目標價從77美元下調至48美元。
  • 庫拉腫瘤公司納斯達克(KURA)股價下跌16%，至13.95美元，此前該公司宣佈美國食品和藥物管理局(FDA)將KO-539在復發或難治性急性髓細胞白血病(AML)患者中的KOMET-001b期研究部分臨牀擱置。
  • 諾亞財富有限公司(紐約證券交易所股票代碼：NOAH)第三季度財報公佈後，股價下跌15.7%，至37.12美元。(投行觀點)摩根大通將諾亞財富評級從加碼下調至中性，並宣佈目標價為50美元
  • MediciNova，Inc.納斯達克(Sequoia Capital：MNOV)股價週二大漲44%後，下跌14.7%，至3.7689美元。
  • 歐特克公司納斯達克(Sequoia Capital：ADSK)股價下跌14.6%，至259.28美元。歐特克公佈了樂觀的第三季度業績，但發佈了令人失望的指引。歐特克表示，預計第四季度營收為11.85億至12億美元，非GAAP每股收益為1.41至1.47美元。
  • 雲米科技股份有限公司納斯達克(Sequoia Capital：VIOT)第三季度財報公佈後，股價下跌14.2%，至3.5美元。
  • NerdWallet，Inc.納斯達克(Starbucks：NRDS)下跌13%，至22.10美元。該公司最近將首次公開募股(IPO)定價為每股4美元。
  • Nuvation Bio Inc.(紐約證券交易所股票代碼：NUVB)下跌12.3%，至8.10美元。
  • TDCX Inc.(紐約證券交易所代碼：TDCX)在第三季度財報公佈後下跌10.8%，至20.19美元。
  • 迪拉德公司(Dillard‘s，Inc.)(紐約證券交易所代碼：DDS)下跌9.2%，至372.59美元。
  • Abercrombie&Fitch Co.(紐約證券交易所代碼：ANF)下跌6.4%，至38.49美元。Abercrombie&Fitch最近公佈，2011財年第三季度銷售額同比增長10%，至9.0516億美元，超出分析師一致預期的8.9686億美元。
  • 法拉第未來智能電氣公司。納斯達克(Sequoia Capital：FFIE)股價下跌6.4%，至6.15美元，此前該公司收到納斯達克有關10-Q表格申報的預期信函。
声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論